BENJAMIN FARKAS: Open Payments
NPI 1346343647 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,639 in 93 payments from 19 companies in 2025. Trend: 2023 $1,211 · 2024 $1,180 · 2025 $1,639
Food & beverage: $1,469Education: $170
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $218 |
| Regeneron Healthcare Solutions, Inc. | 13 | $209 |
| Novartis Pharmaceuticals Corporation | 13 | $206 |
| UCB, Inc. | 8 | $176 |
| Galderma Laboratories, L.P. | 8 | $137 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $135 |
| Journey Medical Corporation | 2 | $122 |
| PFIZER INC. | 4 | $78 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Botanix SB Inc | 2 | $51 |
Products named: TREMFYA, DUPIXENT, Bimzelx, COSENTYX, NEMLUVIO, CIBINQO, Winlevi, Sotyktu.
Industry payments across MD — which companies pay providers there.
